PUSHING THE BOUNDARIES OF NASH RESEARCH: THE FUTURE OF TREATMENT

Nonalcoholic steatohepatitis (NASH) is a progressive liver disease that has become a major global health concern. As its prevalence continues to rise, the need for effective treatment options has led to substantial investment in drug development. Although there are no FDA-approved NASH therapeutics, several promising candidates are in various stage